CD4 and melanoma: A significantly higher number of CD4+T helper (p < 0.05; Figure 2(e)) and CD8+CTLs (p < 0.05; Figure 2(i)) were present in the tumors of B16F10+MSC1d-treated mice than in melanomas of B16F10+PBS1d-treated animals.